Enterprise value of leading pure players in non-oncology rare disease therapeutics worldwide as of 2017 (in million U.S. dollars)*

Enterprise value of top companies in non-oncology rare disease therapeutics 2017 This statistic shows the enterprise value of leading pure players in non-oncology rare disease therapeutics worldwide as of 2017. In 2017, the value of Biogen which manufactures especially multiple sclerosis therapeutics stood at nearly 70 billion U.S. dollars.
Show more
Loading statistic...
Expand statistic
Value in million U.S. dollars
Biogen69,812
Shire (+predecessors)67,777
Vertex Pharma37,428
Genzyme36,070
Alexion33,114
BioMarin16,261
Jazz Pharma10,141
Bioverativ6,086
Ionis Pharma6,053
bluebird bio5,320
United Therapeutics4,225
Swedish Orphan Biovitrum4,073
Horizon Pharma3,409
Spark Therapeutics3,044
AveXis, Inc.2,671
Amicus Therapeutics2,416
Corcept Therapeutics2,127
Prothena Corporation2,060
Ultragenyx1,970
Intercept Pharma1,624
Value in million U.S. dollars
Biogen69,812
Shire (+predecessors)67,777
Vertex Pharma37,428
Genzyme36,070
Alexion33,114
BioMarin16,261
Jazz Pharma10,141
Bioverativ6,086
Ionis Pharma6,053
bluebird bio5,320
United Therapeutics4,225
Swedish Orphan Biovitrum4,073
Horizon Pharma3,409
Spark Therapeutics3,044
AveXis, Inc.2,671
Amicus Therapeutics2,416
Corcept Therapeutics2,127
Prothena Corporation2,060
Ultragenyx1,970
Intercept Pharma1,624
Download Settings Share
Chart type
Datalabels
Share on Social Media
HTML code to embed chart as PNG (FAQ)
Download started
Please be patient - this may take a moment
Description Source More information
This statistic shows the enterprise value of leading pure players in non-oncology rare disease therapeutics worldwide as of 2017. In 2017, the value of Biogen which manufactures especially multiple sclerosis therapeutics stood at nearly 70 billion U.S. dollars.
Show more
Release date
2017
Region
Worldwide
Survey time period
as of October 2017
Special properties
non-oncology rare disease therapeutics
Method of interview
Online survey
Supplementary notes
* All values are in current U.S. dollars.

More information

Statista Accounts: Access All Statistics. Starting from $588 / Year

Basic Account

Get to know the platform

You only have access to basic statistics.

Register for free

Premium Account

Your perfect start with Statista

  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$49 / Month *

Corporate Account

Full access

Corporate solution including all features.

Send request

* All products require an annual contract.
   Prices do not include sales tax
   (New York residents only).
Leading companies trust Statista:
Statista has been my savior on several occasions. The site is easy to maneuver and the data is in a format that can go right into a report or presentation.
Marlene Greenfield

Marlene Greenfield
Vice President, Hearst Magazines

Statistics on "Pharmaceutical trends in Europe"

  • Overview
The most important statistics
  • European Pharmaceutical companies
The most important statistics
  • Self-medication market
The most important statistics
  • Employment
The most important statistics
  • Clinical Trials
The most important statistics
Need help with using Statista for your research? Tutorials and first steps

Further Content: Statistics, Studies, and Topic Pages

Statistics on the topic

Topics

About Statista

Learn more about how Statista can support your business.

Request webinar
Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.

News